Compare Stocks → Does this chart look familiar? (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ACEVUOTCMKTS:ENFAUOTCMKTS:PHICUOTCMKTS:VCVCU Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACEVUACE Convergence Acquisition$9.77-0.1%$9.77$9.27▼$10.80N/AN/A2,197 shs800 shsENFAU890 5th Avenue Partners$9.01-13.9%$9.01$8.99▼$11.05N/AN/A73,340 shs4,700 shsPHICUPopulation Health Investment$10.03$10.03$9.80▼$10.31N/AN/A3,382 shs655 shsVCVCU10X Capital Venture Acquisition$11.15+1.4%$11.15$9.94▼$19.00N/AN/A83,573 shs4,300 shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACEVUACE Convergence Acquisition0.00%0.00%0.00%0.00%0.00%ENFAU890 5th Avenue Partners0.00%0.00%0.00%0.00%0.00%PHICUPopulation Health Investment0.00%0.00%0.00%0.00%0.00%VCVCU10X Capital Venture Acquisition0.00%0.00%0.00%0.00%0.00%Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AENFAU890 5th Avenue PartnersN/AN/AN/AN/AN/AN/AN/AN/APHICUPopulation Health InvestmentN/AN/AN/AN/AN/AN/AN/AN/AVCVCU10X Capital Venture AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACEVUACE Convergence AcquisitionN/AN/AN/AN/AENFAU890 5th Avenue PartnersN/AN/AN/AN/APHICUPopulation Health InvestmentN/AN/AN/AN/AVCVCU10X Capital Venture AcquisitionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AN/AENFAU890 5th Avenue PartnersN/AN/AN/AN/AN/AN/APHICUPopulation Health InvestmentN/AN/AN/AN/AN/AN/AVCVCU10X Capital Venture AcquisitionN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACEVUACE Convergence AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AENFAU890 5th Avenue PartnersN/AN/A0.00∞N/AN/AN/AN/AN/APHICUPopulation Health InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/AVCVCU10X Capital Venture AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AENFAU890 5th Avenue PartnersN/AN/AN/AN/AN/APHICUPopulation Health InvestmentN/AN/AN/AN/AN/AVCVCU10X Capital Venture AcquisitionN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipACEVUACE Convergence AcquisitionN/AENFAU890 5th Avenue PartnersN/APHICUPopulation Health InvestmentN/AVCVCU10X Capital Venture AcquisitionN/AInsider OwnershipCompanyInsider OwnershipACEVUACE Convergence AcquisitionN/AENFAU890 5th Avenue PartnersN/APHICUPopulation Health InvestmentN/AVCVCU10X Capital Venture AcquisitionN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableACEVUACE Convergence Acquisition4N/AN/ANot OptionableENFAU890 5th Avenue Partners8N/AN/ANot OptionablePHICUPopulation Health Investment5N/AN/ANot OptionableVCVCU10X Capital Venture AcquisitionN/AN/AN/ANot OptionablePHICU, VCVCU, ENFAU, and ACEVU HeadlinesRecent News About These CompaniesMay 1, 2024 | msn.com10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call TranscriptApril 26, 2024 | msn.comBest Credit Cards To Pair With the Capital One Venture XApril 16, 2024 | latimes.comCapital One Venture X Credit Card Review: Is it Worth it?April 10, 2024 | crainsdetroit.comVenture capital investments in Michigan continue to declineMarch 20, 2024 | bizjournals.comRC Capital, one of Greater Cincinnati’s oldest and largest private equity firms, raises $250M seventh fundMarch 14, 2024 | msn.com3 Little-Known Perks of the Capital One/Discover MergerFebruary 2, 2024 | washingtontechnology.comCorporate venture and tech leadership moves across the marketJanuary 29, 2024 | forbes.comCapital One And Small Luxury Hotels Of The World Create New Partnership For Venture X CardholdersJanuary 25, 2024 | tmcnet.comVenture Capital Funding in Energy Storage Increases 59% Year-over-Year, with a Record $9.2 Billion in 2023January 23, 2024 | venturebeat.comLaunchbay Capital raises $100M VC fund for secondary growth investmentsJanuary 19, 2024 | newsweek.comCapital One Venture X vs Chase Sapphire Reserve 2024January 11, 2024 | msn.comPentagon Says Venture Capital Needed to Revive Defense BaseNovember 28, 2023 | markets.businessinsider.com10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q FilingNovember 16, 2023 | news.crunchbase.comEye On AI: Bain Capital Ventures Launches BCV Labs In Search Of New AI DealsNovember 15, 2023 | newsweek.comCapital One Venture X Credit Card Review 2023November 12, 2023 | penews.comStalemate over venture capital diversity drive as MPs tussle with governmentNovember 6, 2023 | inc42.comPeak XV Sitting On 10X Gains From Investment In MamaearthOctober 30, 2023 | thestreet.com10X Capital Venture Acquisition Corp. II WarrantOctober 25, 2023 | msn.comThe Venture X Credit Card: Is it Worth It?October 5, 2023 | msn.comVenture capital had a grim quarterMedia Sentiment Over TimeCompany DescriptionsACE Convergence AcquisitionOTCMKTS:ACEVUACE Convergence Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the IT infrastructure software and semiconductor sectors. ACE Convergence Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.890 5th Avenue PartnersOTCMKTS:ENFAU890 Fifth Avenue Partners, Inc. is a principal investment firm that invests in the technology, media, and telecommunications sectors. 890 Fifth Avenue Partners, Inc. was founded in 2020 and is based in New York, New York.Population Health InvestmentOTCMKTS:PHICUPopulation Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.10X Capital Venture AcquisitionOTCMKTS:VCVCU10X Capital Venture Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology and tech-enabled businesses in the United States; and consumer internet, ecommerce, software, healthcare, and financial services industries internationally, as well as other industries that are being disrupted by advances in technology and on technology paradigms. The company was incorporated in 2020 and is based in New York, New York. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
